Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly buys drug patch for $35m

Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical
Eli Lilly & Co has announced that it will buy an osteoporosis drug patch from Israeli company TransPharma Medical.

The drug contains a hormone that stimulates new bone growth. It is designed to be administered with a special device that creates tiny pores in the skin just prior to applying the patch.

Under the terms of the deal, should the patch gain approval, TransPharma will be eligible for milestone payments.

13th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics